|
|
|
|
LEADER |
02049nam a2200253 u 4500 |
001 |
EB002220053 |
003 |
EBX01000000000000001357014 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
240703 r ||| eng |
020 |
|
|
|a 9789240089488
|
020 |
|
|
|a 9789240089495
|
245 |
0 |
0 |
|a WHO consolidated guidelines on tuberculosis, Module 3: Diagnosis
|h Elektronische Ressource
|b rapid diagnostics for tuberculosis detection
|
246 |
3 |
1 |
|a Diagnosis
|
250 |
|
|
|a Third edition
|
260 |
|
|
|a Geneva
|b World Health Organization
|c [2024], 2024
|
300 |
|
|
|a 1 PDF file (xx, 160 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
710 |
2 |
|
|a World Health Organization
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK602005
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The "WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection, third edition" is the latest document replacing the one issued in 2021. This latest edition includes new recommendations on the use of a new class of diagnostic technologies: targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis (TB). The recommendations provide a novel approach for the rapid detection of drug resistance to new anti-TB drugs using the latest technologies. The consolidated guideline provides background, justification and recommendations on these and earlier endorsed TB diagnostic technologies. This document is accompanied by the "WHO operational handbook on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection, third edition", which aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and others involved in managing patients with TB and DR-TB. Access to the WHO operational handbook on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection, third edition
|